Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform
(NASDAQ: ZYME) Delayed: 23.88 +0.62 (2.67%)
Previous Close $23.26    52 Week High $ 
Open $22.90    52 Week Low $ 
Day High $24.27    P/E N/A 
Day Low $22.90    EPS $ 
Volume 623,542